This company has been marked as potentially delisted and may not be actively trading. resTORbio (TORC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock TORC vs. WHWK, VIRI, PYRGF, VHAQ, AADI, OSTX, NBRV, ATNM, EGRX, and ELYMShould you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), Virios Therapeutics (VIRI), PyroGenesis Canada (PYRGF), Viveon Health Acquisition (VHAQ), Aadi Bioscience (AADI), OS Therapies (OSTX), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM), Eagle Pharmaceuticals (EGRX), and Eliem Therapeutics (ELYM). resTORbio vs. Its Competitors Whitehawk Therapeutics Virios Therapeutics PyroGenesis Canada Viveon Health Acquisition Aadi Bioscience OS Therapies Nabriva Therapeutics Actinium Pharmaceuticals Eagle Pharmaceuticals Eliem Therapeutics resTORbio (NASDAQ:TORC) and Whitehawk Therapeutics (NASDAQ:WHWK) are both small-cap pharmaceutical preparations industry companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, earnings, profitability, institutional ownership, valuation, media sentiment and analyst recommendations. Does the media prefer TORC or WHWK? In the previous week, resTORbio's average media sentiment score of 0.00 equaled Whitehawk Therapeutics'average media sentiment score. Company Overall Sentiment resTORbio Neutral Whitehawk Therapeutics Neutral Which has better valuation and earnings, TORC or WHWK? Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioresTORbioN/AN/A-$82.74M-$2.41-0.28Whitehawk Therapeutics$25.98M3.66-$63.69M$0.1612.63 Which has more risk & volatility, TORC or WHWK? resTORbio has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500. Comparatively, Whitehawk Therapeutics has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Do insiders and institutionals believe in TORC or WHWK? 46.2% of resTORbio shares are held by institutional investors. Comparatively, 52.1% of Whitehawk Therapeutics shares are held by institutional investors. 11.8% of resTORbio shares are held by company insiders. Comparatively, 49.9% of Whitehawk Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is TORC or WHWK more profitable? Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.Company Net Margins Return on Equity Return on Assets resTORbioN/A -78.12% -71.63% Whitehawk Therapeutics 99.42%-56.73%-48.68% SummaryWhitehawk Therapeutics beats resTORbio on 9 of the 10 factors compared between the two stocks. Get resTORbio News Delivered to You Automatically Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TORC vs. The Competition Export to ExcelMetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ ExchangeMarket Cap$24.89M$790.52M$5.54B$8.99BDividend YieldN/A4.84%5.25%4.04%P/E Ratio-0.381.3027.5520.17Price / SalesN/A225.41432.66125.29Price / CashN/A23.4436.8257.86Price / Book0.306.138.105.60Net Income-$82.74M-$27.58M$3.17B$248.58M resTORbio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TORCresTORbioN/A$0.68+5.2%N/A-39.3%$24.89MN/A-0.38N/AWHWKWhitehawk TherapeuticsN/A$1.99+0.5%N/AN/A$93.28M$25.98M0.0040VIRIVirios TherapeuticsN/A$4.80-0.6%$5.00+4.2%+1,782.4%$92.44MN/A-17.785Gap UpPYRGFPyroGenesis Canada0.1033 of 5 stars$0.35-2.5%N/A-43.0%$64.48M$9.14M-5.7690News CoverageGap DownVHAQViveon Health AcquisitionN/A$11.00flatN/A+10.0%$62.26MN/A0.002High Trading VolumeAADIAadi Bioscience0.645 of 5 stars$1.98-0.5%$1.67-15.8%+44.5%$48.90M$25.07M-0.8740OSTXOS Therapies2.7842 of 5 stars$1.62-6.4%$18.00+1,011.1%N/A$45.52MN/A-1.88N/ANBRVNabriva TherapeuticsN/AN/AN/AN/A$45.46M$35.59M0.0070ATNMActinium Pharmaceuticals2.9553 of 5 stars$1.43+0.7%$4.00+179.7%N/A$44.61MN/A-1.0330Positive NewsEGRXEagle PharmaceuticalsN/A$3.25+8.3%N/A-45.9%$42.21M$257.55M0.00100ELYMEliem TherapeuticsN/A$1.28+1.6%N/A-81.1%$38.08MN/A-2.429 Related Companies and Tools Related Companies Whitehawk Therapeutics Alternatives Virios Therapeutics Alternatives PyroGenesis Canada Alternatives Viveon Health Acquisition Alternatives Aadi Bioscience Alternatives OS Therapies Alternatives Nabriva Therapeutics Alternatives Actinium Pharmaceuticals Alternatives Eagle Pharmaceuticals Alternatives Eliem Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TORC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding resTORbio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share resTORbio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TORC Stock Alerts